Zelenitsky S - Search Results

1

Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.

Zhanel GG, Lawrence CK, Adam H, Schweizer F, Zelenitsky S, Zhanel M, Lagacé-Wiens PRS, Walkty A, Denisuik A, Golden A, Gin AS, Hoban DJ, Lynch JP 3rd, Karlowsky JA. Zhanel GG, et al. Among authors: zelenitsky s. Drugs. 2018 Jan;78(1):65-98. doi: 10.1007/s40265-017-0851-9. Drugs. 2018. PMID: 29230684 Review.

2

Phenazopyridine in urinary tract infections.

Zelenitsky SA, Zhanel GG. Zelenitsky SA, et al. Ann Pharmacother. 1996 Jul-Aug;30(7-8):866-8. doi: 10.1177/106002809603000727. Ann Pharmacother. 1996. PMID: 8826573 Review. No abstract available.

3

In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species.

Zhanel GG, Karlowsky JA, Harding GA, Balko TV, Zelenitsky SA, Friesen M, Kabani A, Turik M, Hoban DJ. Zhanel GG, et al. Among authors: zelenitsky sa. Antimicrob Agents Chemother. 1997 Apr;41(4):863-5. doi: 10.1128/AAC.41.4.863. Antimicrob Agents Chemother. 1997. PMID: 9087508 Free PMC article.

4

Aminoglycoside adaptive resistance.

Karlowsky JA, Zelenitsky SA, Zhanel GG. Karlowsky JA, et al. Among authors: zelenitsky sa. Pharmacotherapy. 1997 May-Jun;17(3):549-55. Pharmacotherapy. 1997. PMID: 9165557 Review.

5

Time-kill curves for a semisynthetic glycopeptide, LY333328, against vancomycin-susceptible and vancomycin-resistant Enterococcus faecium strains.

Zelenitsky SA, Karlowsky JA, Zhanel GG, Hoban DJ, Nicas T. Zelenitsky SA, et al. Antimicrob Agents Chemother. 1997 Jun;41(6):1407-8. doi: 10.1128/AAC.41.6.1407. Antimicrob Agents Chemother. 1997. PMID: 9174212 Free PMC article. No abstract available.

6

In vitro antifungal activity of BMS-181184 against systemic isolates of Candida, Cryptococcus, and Blastomyces species.

Karlowsky JA, Zhanel GG, Balko TV, Zelenitsky SA, Kabani AM, Hoban DJ. Karlowsky JA, et al. Among authors: zelenitsky sa. Diagn Microbiol Infect Dis. 1997 Aug;28(4):179-82. doi: 10.1016/s0732-8893(97)00061-8. Diagn Microbiol Infect Dis. 1997. PMID: 9327245

7

Altered denA and anr gene expression in aminoglycoside adaptive resistance in Pseudomonas aeruginosa.

Karlowsky JA, Hoban DJ, Zelenitsky SA, Zhanel GG. Karlowsky JA, et al. Among authors: zelenitsky sa. J Antimicrob Chemother. 1997 Sep;40(3):371-6. doi: 10.1093/jac/40.3.371. J Antimicrob Chemother. 1997. PMID: 9338489

8

In vitro kill curves of a new semisynthetic echinocandin, LY-303366, against fluconazole-sensitive and -resistant Candida species.

Karlowsky JA, Harding GA, Zelenitsky SA, Hoban DJ, Kabani A, Balko TV, Turik M, Zhanel GG. Karlowsky JA, et al. Among authors: zelenitsky sa. Antimicrob Agents Chemother. 1997 Nov;41(11):2576-8. doi: 10.1128/AAC.41.11.2576. Antimicrob Agents Chemother. 1997. PMID: 9371373 Free PMC article.

9

Once versus thrice daily tobramycin alone and in combination with ceftazidime, ciprofloxacin and imipenem in an in vitro pharmacodynamic model.

Zelenitsky SA, Karlowsky JA, Hoban DJ, Kabani A, Zhanel GG. Zelenitsky SA, et al. Chemotherapy. 1998 Jan-Feb;44(1):1-6. doi: 10.1159/000007083. Chemotherapy. 1998. PMID: 9444401

10

Susceptibilities of Candida species isolated from the lower gastrointestinal tracts of high-risk patients to the new semisynthetic echinocandin LY303366 and other antifungal agents.

Zhanel GG, Karlowsky JA, Zelenitsky SA, Turik MA, Hoban DJ. Zhanel GG, et al. Among authors: zelenitsky sa. Antimicrob Agents Chemother. 1998 Sep;42(9):2446-8. doi: 10.1128/AAC.42.9.2446. Antimicrob Agents Chemother. 1998. PMID: 9736582 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page